Paclitaxel protein-bound for Non Small Cell Lung Cancer User Reviews
Brand names: Abraxane
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Methotrexate
Methotrexate is used to treat certain types of cancer of the breast, skin, head and neck, or lung ...
Are you taking this medicine?
Your review helps others make informed decisions.More about paclitaxel protein-bound
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Side effects
- Dosage information
- During pregnancy
- Drug class: mitotic inhibitors
- En español
"My husband, who is 74 years old, suffers from lung and trachea cancer. He receives three Abraxane infusions in three consecutive weeks. The reaction was brutal. You could say he had all the possible side effects and then some. Almost 2 months after treatment and after two hospital admissions, one of them in Intensive Care, he still feels extremely weak. Hard to believe that a medication supposed to help you live can almost kill you. I also want to mention the extremely high cost of Abraxane. We end up paying a deductible of $2,500, and we have Humana Medicare. Three treatments cost the staggering amount of $13,500."